Treace Medical Concepts TMCI Stock
Treace Medical Concepts Price Chart
Treace Medical Concepts TMCI Financial and Trading Overview
| Treace Medical Concepts stock price | 11.88 USD |
| Previous Close | 25.62 USD |
| Open | 25.62 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 25.1 - 26.06 USD |
| 52 Week Range | 13.39 - 27.97 USD |
| Volume | 241.49K USD |
| Avg. Volume | 359.28K USD |
| Market Cap | 1.55B USD |
| Beta (5Y Monthly) | -0.009537 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.81 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.4 USD |
TMCI Valuation Measures
| Enterprise Value | 1.47B USD |
| Trailing P/E | N/A |
| Forward P/E | -44.368423 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.007831 |
| Price/Book (mrq) | 9.832815 |
| Enterprise Value/Revenue | 9.48 |
| Enterprise Value/EBITDA | -38.867 |
Trading Information
Treace Medical Concepts Stock Price History
| Beta (5Y Monthly) | -0.009537 |
| 52-Week Change | 71.92% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 27.97 USD |
| 52 Week Low | 13.39 USD |
| 50-Day Moving Average | 25.95 USD |
| 200-Day Moving Average | 23.82 USD |
TMCI Share Statistics
| Avg. Volume (3 month) | 359.28K USD |
| Avg. Daily Volume (10-Days) | 401.85K USD |
| Shares Outstanding | 61.33M |
| Float | 43.11M |
| Short Ratio | 4.11 |
| % Held by Insiders | 31.73% |
| % Held by Institutions | 50.02% |
| Shares Short | 1.4M |
| Short % of Float | 4.13% |
| Short % of Shares Outstanding | 2.29% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -30.47% |
| Operating Margin (ttm) | -26.14% |
| Gross Margin | 80.36% |
| EBITDA Margin | -24.39% |
Management Effectiveness
| Return on Assets (ttm) | -12.80% |
| Return on Equity (ttm) | -38.64% |
Income Statement
| Revenue (ttm) | 154.99M USD |
| Revenue Per Share (ttm) | 2.76 USD |
| Quarterly Revenue Growth (yoy) | 45.30% |
| Gross Profit (ttm) | 114.32M USD |
| EBITDA | -37801000 USD |
| Net Income Avi to Common (ttm) | -47233000 USD |
| Diluted EPS (ttm) | -0.85 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 170.66M USD |
| Total Cash Per Share (mrq) | 2.78 USD |
| Total Debt (mrq) | 68.58M USD |
| Total Debt/Equity (mrq) | 43.51 USD |
| Current Ratio (mrq) | 9.578 |
| Book Value Per Share (mrq) | 2.572 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -40666000 USD |
| Levered Free Cash Flow (ttm) | -46365000 USD |
Profile of Treace Medical Concepts
| Country | United States |
| State | FL |
| City | Ponte Vedra |
| Address | 100 Palmetto Park Place |
| ZIP | 32081 |
| Phone | 904 373 5940 |
| Website | https://www.treace.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 423 |
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision; and Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Q&A For Treace Medical Concepts Stock
What is a current TMCI stock price?
Treace Medical Concepts TMCI stock price today per share is 11.88 USD.
How to purchase Treace Medical Concepts stock?
You can buy TMCI shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Treace Medical Concepts?
The stock symbol or ticker of Treace Medical Concepts is TMCI.
Which industry does the Treace Medical Concepts company belong to?
The Treace Medical Concepts industry is Medical Devices.
How many shares does Treace Medical Concepts have in circulation?
The max supply of Treace Medical Concepts shares is 61.94M.
What is Treace Medical Concepts Price to Earnings Ratio (PE Ratio)?
Treace Medical Concepts PE Ratio is now.
What was Treace Medical Concepts earnings per share over the trailing 12 months (TTM)?
Treace Medical Concepts EPS is -0.81 USD over the trailing 12 months.
Which sector does the Treace Medical Concepts company belong to?
The Treace Medical Concepts sector is Healthcare.
Treace Medical Concepts TMCI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2060.1 USD — |
-1.99
|
— — | 2051.95 USD — | 2093.4 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2541.54 USD — |
-1.89
|
— — | 2531.95 USD — | 2572.66 USD — | — - | — — |
- {{ link.label }} {{link}}